Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure

International Journal of Obesity

Volumn 39, Issue 8, 2015, Pages 1300-1309

  Xu, C X ^a   Wang, C ^a   Zhang, Z M ^a,b   Jaeger, C D ^a   Krager, S L ^a   Bottum, K M ^a   Liu, J ^c   Liao, D F ^d   Tischkau, S A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

^c THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^d HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; FAT; INSULIN; LIPID; MITOCHONDRIAL PROTEIN; UNCOUPLING PROTEIN 1; AHR PROTEIN, MOUSE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIET; DIET INDUCED OBESITY; DIETARY INTAKE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION PROFILING; HETEROZYGOTE; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; MOUSE; MUSCLE; NONHUMAN; NORMAL CHOW DIET; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; DEFICIENCY; DISEASE MODEL; ENERGY METABOLISM; GENE EXPRESSION REGULATION; METABOLISM; OBESITY;

MUS;

ADIPOSE TISSUE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MICE; OBESITY; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 84938741067     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.63     Document Type: Article

References (38)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311: 806-814
2. Wright SM, Aronne LJ. Causes of obesity. Abdom Imaging 2012; 37: 730-732
3. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53: 409-435
4. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H et al. Peroxisome-proliferatoractivated receptor delta activates fat metabolism to prevent obesity. Cell 2003; 113: 159-170
5. He J, Gao J, Xu M, Ren S, Stefanovic-Racic M, O'Doherty RM et al. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes 2013; 62: 1876-1887
6. Spruiell K, Richardson RM, Cullen JM, Awumey EM, Gonzalez FJ, Gyamfi MA. Role of pregnane X receptor in obesity and glucose homeostasis in male mice. J Biol Chem 2014; 289: 3244-3261
7. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 1997; 8: 252-258
8. Fujiyoshi PT, Michalek JE, Matsumura F. Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war. Environ Health Perspect 2006; 114: 1677-1683
9. Warner M, Mocarelli P, Brambilla P, Wesselink A, Samuels S, Signorini S et al. Diabetes, metabolic syndrome, and obesity in relation to serum dioxin concentrations: The Seveso Women's Health Study. Environ Health Perspect 2013; 121: 906-911
10. Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, Devito M et al. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect 2013; 121: 774-783
11. Lee HK. Mitochondrial dysfunction and insulin resistance: the contribution of dioxin-like substances. Diabetes Metab J 2011; 35: 207-215
12. Nishiumi S, Yoshida M, Azuma T, Yoshida K, Ashida H. 2, 3, 7, 8-tetrachlorodibenzop- dioxin impairs an insulin signaling pathway through the induction of tumor necrosis factor-alpha in adipocytes. Toxicol Sci 2010; 115: 482-491
13. He J, Hu B, Shi X, Weidert ER, Lu P, Xu M et al. Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Mol Cell Biol 2013; 33: 2047-2055
14. Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 2008; 116: 761-768
15. Kerley-Hamilton JS, Trask HW, Ridley CJ, Dufour E, Ringelberg CS, Nurinova N et al. Obesity is mediated by differential aryl hydrocarbon receptor signaling in mice fed a Western diet. Environ Health Perspect 2012; 120: 1252-1259
16. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 1996; 93: 6731-6736
17. Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, Kahn CR et al. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 2002; 99: 419-424
18. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72: 219-246
19. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445
20. Tarantino G, Finelli C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol 2013; 19: 3375-3384
21. Ruzzin J, Petersen R, Meugnier E, Madsen L, Lock EJ, Lillefosse H et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect 2010; 118: 465-471
22. Lee JH, Wada T, Febbraio M, He J, Matsubara T, Lee MJ et al. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology 2010; 139: 653-663
23. Wang C, Xu CX, Krager SL, Bottum KM, Liao DF, Tischkau SA. Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-alpha pathway activity in mice. Environ Health Perspect 2011; 119: 1739-1744
24. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920
25. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-929
26. Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15: 940-945
27. Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012; 18: 1407-1412
28. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17: 610-617
29. Zhou Y, Tung HY, Tsai YM, Hsu SC, Chang HW, Kawasaki H et al. Aryl hydrocarbon receptor controls murine mast cell homeostasis. Blood 2013; 121: 3195-3204
30. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004; 53: S43-S50
31. Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 2001; 276: 5629-5635
32. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T et al. 'New' hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 2005; 1: 309-322
33. Kajimura S, Seale P, Spiegelman BM. Transcriptional control of brown fat development. Cell Metab 2010; 11: 257-262
34. Kajimura S, Saito M. A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. Annu Rev Physiol 2014; 76: 225-249
35. McMillan BJ, Bradfield CA. The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc Natl Acad Sci USA 2007; 104: 1412-1417
36. Julliard W, Fechner JH, Mezrich JD. The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both. Front Immunol 2014; 5: 458
37. Murray IA, Patterson AD, Perdew GH. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat Rev Cancer 2014; 14: 801-814
38. Wang C, Zhang ZM, Xu CX, Tischkau SA. Interplay between Dioxin-mediated signaling and circadian clock: a possible determinant in metabolic homeostasis. Int J Mol Sci 2014; 15: 11700-11712